31 Jan 2022 , 04:24 PM
Net profit of Ajanta Pharma rose 8.58% to Rs 191.78 crore in the quarter ended December 2021 as against Rs 176.63 crore during the previous quarter ended December 2020. Sales rose 11.91% to Rs 837.91 crore in the quarter ended December 2021 as against Rs 748.74 crore during the previous quarter ended December 2020.
| Particulars | Quarter Ended | ||
| ? | Dec. 2021 | Dec. 2020 | % Var. |
| Sales | 837.91 | 748.74 | 12 |
| OPM % | 28.59 | 32.28 | – |
| PBDT | 262.66 | 244.61 | 7 |
| PBT | 230.94 | 215.47 | 7 |
| NP | 191.78 | 176.63 | 9 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
